Lupin's Escitalopram tablets are the AB rated generic equivalent of Lexapro tablets indicated for treatment of major depressive disorder. The brand product had annual sales of approximately $2.6 bn for the month end March 2008 based on IMS health sales data.
With this approval, the cummulative ANDA approvals stands at 30(including 3 tentative approvals) with 33 pending approvals from USFDA.
